SPIMA Therapeutics
PrivateLast Round
Seed
Sep 30, 2024
Total Funding Raised
$1.12M
Company Overview
SPIMA Therapeutics is a biotechnology company that develops innovative peptide-based immunotherapies to address undruggable targets and protein-protein interactions for the treatment of severe immunological disorders and aggressive cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPIMA Therapeutics Comparables
Compare SPIMA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duhn Therapeutics | 72% | |
| BiPER Therapeutics | 71% | |
| Massalia Therapeutics | 71% | |
SPIMA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 30, 2024 |
SPIMA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT AxLR | Seed |
SPIMA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SPIMA Therapeutics's valuation, stock price, and market status.